Victor Ganzi Net Worth: How It’s Estimated and Verified

Victor F. Ganzi's estimated net worth sits somewhere between $3 million and $14.7 million as of early 2026, depending on which estimator you use and how they're counting his publicly disclosed stock holdings. The most defensible floor is around $3 to $4 million based on verified SEC insider filings, while higher estimates like Benzinga's $14.7 million figure factor in a broader view of his equity positions across multiple companies. None of these numbers include private assets like real estate or private investments, so the real figure is likely higher than any of the public estimates.

Who Victor Ganzi is (and who he isn't)

Victor F. Ganzi is a New York City-born corporate executive, lawyer, and CPA with a specialization in taxation. He's best known for serving as President and CEO of Hearst Corporation from 2002 to 2008, when he ran one of the largest privately held media companies in the United States. His tenure ended abruptly in June 2008 following what was publicly described as "irreconcilable policy differences" with the board and trustees. Since then, he's remained active in the corporate world, most notably as Non-Executive Chairman of Willis Towers Watson, a role he took on in January 2019 after joining that board in January 2016. He's also served on the boards of Aveanna Healthcare Holdings (AVAH) and Angion Biomedica, and has been affiliated with more than 25 public, private, and non-profit boards throughout his career.

On the disambiguation front: there are multiple individuals named Victor Ganzi in various databases, so it's worth being precise. The person this article covers is Victor Frederick Ganzi, born in February 1947, who appears in SEC insider trading records under CIK 0001199070 and in UK Companies House records as Victor Frederick GANZI. If you've landed here looking for a different Victor Ganzi, the SEC EDGAR system and Companies House are the quickest ways to verify which one you're looking at. The net worth data on financial sites like CoreStreet, GuruFocus, QuiverQuant, and Benzinga all refer to this same Victor F. If you are looking specifically for the victor kislyi net worth figure, you will want to compare how each estimator values the same underlying disclosed holdings net worth data on financial sites. Ganzi, tied to his disclosed insider equity holdings at Aveanna Healthcare and Angion Biomedica.

How net worth estimates actually get calculated

Net worth, in principle, is simple: total assets minus total liabilities. In practice, for a private individual like Victor Ganzi who isn't a billionaire with splashy Forbes coverage, the calculation is much more limited. If you want a more direct, number-focused snapshot of victor cui net worth, pair this methodology with the current estimator ranges and dates. Estimators like CoreStreet, GuruFocus, QuiverQuant, and Benzinga work almost exclusively from public SEC filings, specifically Form 4 insider trading disclosures and beneficial ownership tables in annual reports and proxy statements. If you're specifically trying to narrow down victor xiao net worth figures, start with the same SEC- and filings-based approach this article outlines. Net worth estimates for Victor Qin vary widely depending on which public filings and valuation assumptions are used Victor Qin net worth. They take the number of shares an insider holds, multiply by the current stock price, add in any documented sale proceeds, and arrive at a floor estimate. The word "floor" matters here: these tools are explicitly measuring minimum equity-based wealth from publicly traceable sources only. For readers who want a different profile and the way net worth estimates vary by person, see also victor chu net worth as a related comparison point.

What they're not measuring is equally important. Private investments, real estate, bank accounts, retirement accounts, compensation received as cash, board fees paid outside of equity, and liabilities like mortgages or loans are all invisible to these tools unless they show up in a public filing. So when CoreStreet says Ganzi's net worth is "at least $3,953,546.12" as of April 2026, the phrase "at least" is doing a lot of work. It's a traceable minimum, not a total picture.

The estimated net worth range and what it's based on

Here's a quick snapshot of what the major estimators are showing for Victor F. Ganzi as of early-to-mid 2026:

The spread between $3 million and $14.7 million reflects different methodologies and different snapshots in time, not conflicting facts. Sites that pull a narrower slice of filings (or use older data) land at the lower end. Sites that aggregate across all companies where Ganzi has held equity, and apply current or more recent stock prices, land higher. For a practical working estimate, a range of $5 million to $15 million is reasonable when you account for the likelihood that his total wealth exceeds what's visible in equity disclosures alone.

Income sources and career earnings breakdown

Victor Ganzi's wealth comes from several distinct career phases, each with its own income profile.

Hearst Corporation (CEO, 2002-2008)

As President and CEO of a major private media conglomerate, Ganzi would have received executive compensation typical of that tier of corporate leadership: a base salary, annual bonus, and likely deferred compensation or equity equivalent arrangements. Because Hearst is privately held, exact figures were never publicly disclosed. This phase of his career is the largest unknown in his wealth picture, but six years running a media empire of that scale almost certainly contributed substantially to his overall net worth.

Board roles and equity compensation

Since leaving Hearst, Ganzi's documented income has come primarily from board positions. His most visible role is Non-Executive Chairman of Willis Towers Watson, a position he's held since January 2019. Chairman-level compensation at a company of WTW's scale typically includes a combination of annual cash retainers and equity grants (restricted stock units or options), though specific figures would need to be extracted from WTW's proxy compensation tables. He's also served on the boards of Aveanna Healthcare Holdings and Angion Biomedica, both of which come with their own compensation and equity grants.

Documented stock transactions

The most concrete income milestone on the public record is a large stock sale: CoreStreet documents that Ganzi sold 246,720 units of Angion Biomedica Corp stock for $3,947,520 on February 9, 2021. That's nearly $4 million in a single transaction, and it gives you a concrete anchor for his equity-based wealth. His most recent documented trade is a purchase of 200 units of AVAH (Aveanna Healthcare) stock on June 6, 2023, suggesting continued active management of his portfolio.

Assets, investments, and liabilities: what's known versus assumed

What's verifiable

• Equity holdings in Aveanna Healthcare Holdings (AVAH), documented in SEC Form 4 filings under CIK 0001199070
• Prior equity holdings in Angion Biomedica (ANGN), including beneficial ownership through family trusts and holding entities as listed in ANGN annual filings
• At least $3.95 million in documented stock sale proceeds from the February 2021 Angion Biomedica transaction
• Ongoing board compensation from Willis Towers Watson (Non-Executive Chairman since January 2019), Aveanna Healthcare, and previously Angion Biomedica

What's assumed or unknown

• Real estate holdings: no public data available
• Cash, bank, and retirement accounts: not disclosed in any public filing
• Hearst Corporation compensation (2002-2008): private company, never disclosed
• Private investments or venture holdings outside SEC-tracked public companies
• Liabilities including mortgages, loans, or other obligations
• Compensation details from Willis Towers Watson (would require reading full proxy compensation tables)

The beneficial ownership tables in Angion Biomedica's filings also reference family trust and holding entities tied to Ganzi, which is a common structure for executives managing concentrated equity positions. This suggests a level of financial planning and asset structuring that goes well beyond what's visible in raw share counts.

How to verify the estimate and resolve conflicting numbers

If you want to check these numbers yourself rather than taking any estimator's figure at face value, here's the most reliable path:

1. Start with SEC EDGAR. Search for "GANZI VICTOR F" or CIK 0001199070. Look at Form 4 filings to see every documented insider transaction, including dates, share counts, and prices. This is the primary source all estimator sites are drawing from.
2. Check beneficial ownership tables. Pull annual reports (10-K filings) and proxy statements (DEF 14A) for Aveanna Healthcare Holdings and previously Angion Biomedica. These tables list exact share counts and any trust/entity structures holding shares on his behalf.
3. Review the Willis Towers Watson proxy (DEF 14A). This confirms his role as Non-Executive Chairman since January 2019 and may include compensation table data relevant to his board earnings.
4. Compare which transaction date and share price each estimator is using. If one site's figure looks wildly off, it's usually because it's using an older share price or a narrower set of companies. Form 4 filings give you the authoritative transaction timeline.
5. Use UK Companies House as an identity check. Searching "Victor Frederick GANZI" with a February 1947 birth date can help confirm you're looking at the right person if you encounter any name collision issues.
6. For high-level career corroboration, press coverage from The Conference Board, Forbes, and Business Insurance confirming his Hearst CEO tenure and WTW chairmanship are useful identity anchors, even if they don't contain financial specifics.

When you see a gap as wide as $3 million versus $14.7 million across different sites, the explanation is almost always methodological, not a data error. CoreStreet and MarketScreener are conservative, anchoring to current equity holdings in a narrow set of companies. Benzinga applies a broader multi-company lens and may use more current stock prices. Neither is wrong, they're just measuring different slices of the same elephant.

How his net worth could change from here

The most direct driver of any change in publicly tracked estimates is new SEC Form 4 activity. If Ganzi buys or sells shares at Aveanna Healthcare or picks up equity at a new company through a board appointment, those transactions will show up in EDGAR filings and the estimator sites will recalculate. Benzinga already demonstrated this dynamic by recalculating its estimate as recently as July 16, 2025, and QuiverQuant updated its figure as of March 11, 2026. These aren't static numbers.

A few specific things worth watching: any new board appointments that come with equity grants, changes in AVAH's stock price (since his current holdings are concentrated there), and whether any further large block sales similar to the $3.95 million Angion transaction appear in future filings. Stock price movement alone can shift equity-based estimates significantly without any new transactions occurring. His WTW chairmanship also potentially carries ongoing equity grants that may not yet be fully reflected in all estimates, depending on vesting schedules.

It's also worth noting that private executives with Ganzi's career profile often accumulate wealth through channels that simply don't appear in SEC data. Deferred compensation from Hearst, private equity co-investments, and real estate are all plausible but undocumented contributors. So while the public estimates will move with SEC filings, the real net worth could shift from entirely different directions without any public signal. For a fuller picture, any future interviews, biographical profiles, or public financial disclosures tied to new roles would be the place to look.